Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ADMA | ADMA Biologics, Inc.

Index	RUT	P/E	-	EPS (ttm)	-0.20	Insider Own	1.50%	Shs Outstand	222.68M	Perf Week	-6.33%
Market Cap	809.08M	Forward P/E	30.34	EPS next Y	0.12	Insider Trans	-41.53%	Shs Float	202.66M	Perf Month	-12.13%
Income	-40.30M	PEG	-	EPS next Q	-0.01	Inst Own	67.30%	Short Float / Ratio	4.37% / 4.11	Perf Quarter	-10.13%
Sales	208.10M	P/S	3.89	EPS this Y	35.10%	Inst Trans	7.42%	Short Interest	8.86M	Perf Half Y	14.52%
Book/sh	0.66	P/B	5.38	EPS next Y	271.40%	ROA	-12.10%	Target Price	6.00	Perf Year	37.07%
Cash/sh	0.27	P/C	12.95	EPS next 5Y	-	ROE	-29.60%	52W Range	2.24 - 4.65	Perf YTD	-8.51%
Dividend	-	P/FCF	-	EPS past 5Y	29.50%	ROI	-15.60%	52W High	-23.66%	Beta	0.81
Dividend %	-	Quick Ratio	2.50	Sales past 5Y	46.60%	Gross Margin	27.40%	52W Low	58.48%	ATR	0.15
Employees	617	Current Ratio	6.30	Sales Q/Q	77.30%	Oper. Margin	-8.00%	RSI (14)	34.29	Volatility	3.77% 3.76%
Optionable	Yes	Debt/Eq	0.96	EPS Q/Q	59.20%	Profit Margin	-19.40%	Rel Volume	0.74	Prev Close	3.65
Shortable	Yes	LT Debt/Eq	0.96	Earnings	Aug 09 AMC	Payout	-	Avg Volume	2.16M	Price	3.55
Recom	1.70	SMA20	-7.19%	SMA50	-9.44%	SMA200	-3.19%	Volume	1,584,942	Change	-2.74%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-19-23	Resumed	Raymond James	Strong Buy	$5
Oct-13-22	Initiated	Mizuho	Buy	$5
Nov-11-21	Upgrade	Raymond James	Outperform → Strong Buy	$5
Nov-09-21	Initiated	Cantor Fitzgerald	Overweight	$4.50
Jun-04-19	Initiated	Jefferies	Buy	$8
Apr-15-19	Reiterated	H.C. Wainwright	Buy	$10 → $13
Feb-07-19	Resumed	H.C. Wainwright	Buy	$10
Dec-11-17	Reiterated	Maxim Group	Buy	$13 → $8
Nov-14-17	Upgrade	Raymond James	Mkt Perform → Outperform
Jan-23-17	Upgrade	Maxim Group	Hold → Buy	$13
Aug-01-16	Downgrade	Maxim Group	Buy → Hold
Jul-25-16	Reiterated	Maxim Group	Buy	$24 → $14
May-13-15	Reiterated	Maxim Group	Buy	$18 → $24
Dec-08-14	Initiated	Oppenheimer	Outperform	$20
Dec-01-14	Reiterated	Maxim Group	Buy	$16 → $18

Show Previous Ratings

Sep-14-23 05:50PM	Adma Biologics (ADMA) Stock Sinks As Market Gains: What You Should Know (Zacks)
Sep-13-23 09:30AM	Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views? (Zacks)
Aug-10-23 02:31PM	Why Shares of ADMA Biologics Are Climbing Thursday (Motley Fool) +6.16%
11:50AM	ADMA Biologics, Inc.'s (NASDAQ:ADMA) Profit Outlook (Simply Wall St.)
09:40AM	Is ADMA Biologics (ADMA) Outperforming Other Medical Stocks This Year? (Zacks)
06:46AM	Loading…
06:46AM	Q2 2023 ADMA Biologics Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-09-23 06:40PM	Adma Biologics (ADMA) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
05:37PM	Adma Biologics: Q2 Earnings Snapshot (AP Finance)
04:05PM	ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Aug-02-23 07:00AM	ADMA Biologics to Report Second Quarter 2023 Financial Results on August 9, 2023 (GlobeNewswire)
Jul-28-23 08:59AM	ADMA Biologics (ADMA) to Report Q2 Earnings: What's in Store? (Zacks)
Jul-26-23 11:30AM	2 Biotech Stocks to Watch as Their Growth Stories Brighten (TheStreet.com)
Jul-25-23 05:12PM	Load Up, Says Raymond James About These 2 Strong Buy Stocks (TipRanks)
Jul-20-23 05:50PM	Adma Biologics (ADMA) Gains As Market Dips: What You Should Know (Zacks)
Jul-19-23 07:00AM	ADMA BioCenters Receives FDA Approval for its Ninth Plasma Collection Center, Located in Dallas, GA (GlobeNewswire)
05:50PM	Loading…
Jul-13-23 05:50PM	Adma Biologics (ADMA) Gains But Lags Market: What You Should Know (Zacks)
Jul-07-23 07:32AM	New Strong Buy Stocks for July 7th (Zacks)
Jun-23-23 10:31AM	Aeglea (AGLE) Soars 329% on Acquiring Spyre Therapeutics (Zacks)
Jun-22-23 09:18AM	Alderya (ALDX) Stock Declines on Getting CRL for PVRL Candidate (Zacks)
Jun-21-23 03:21PM	Denali (DNLI) Provides Update on Hunter Syndrome Study (Zacks)
10:46AM	Merck's (MRK) Gastric Cancer Study Fails to Meet a Primary Goal (Zacks)
Jun-19-23 10:28AM	Reata (RETA) Announces FDA's Acceptance of Skyclarys PAS (Zacks)
Jun-16-23 10:43AM	Mersana (MRSN) Down on Partial Ovarian Cancer Study Hold (Zacks)
10:26AM	Aldeyra (ALDX) Up On Positive Data From Conjunctivitis Study (Zacks)
Jun-14-23 12:17PM	Can-Fite (CANF) Up on Namodenoson Progress in Pancreatic Cancer (Zacks)
11:48AM	Recursion (RXRX) Up on Completing REC-994 Study Enrollment (Zacks)
09:40AM	Is InMode (INMD) Outperforming Other Medical Stocks This Year? (Zacks)
Jun-13-23 09:18AM	Ironwood (IRWD), AbbVie Get FDA Nod for Linzess Label Expansion (Zacks)
Jun-08-23 11:49AM	Timber (TMBR) Surges on Carcinogenicity Waiver for TMB-001 (Zacks)
11:20AM	AVITA (RCEL) Gets FDA Nod for Expanded Use of RECELL System (Zacks)
12:31PM	Loading…
Jun-07-23 12:31PM	Alkermes (ALKS) Gets Final Award in Janssen Arbitration, Ups View (Zacks)
Jun-06-23 11:14AM	Ultragenyx (RARE) Posts Data From Osteogenesis Imperfecta Study (Zacks)
Jun-05-23 12:43PM	BioNTech (BNTX) Up on Initial Data From Lung Cancer Antibody (Zacks)
10:22AM	Bristol Myers (BMY) Announces Upbeat Data From NSCLC Study (Zacks)
Jun-02-23 10:59AM	LAVA (LVTX) Up on J&J's (JNJ) Cancer Study Candidate Selection (Zacks)
Jun-01-23 11:59AM	Genprex (GNPX) Up on Advancing Early-Stage NSCLC Study (Zacks)
May-31-23 10:46AM	J&J (JNJ) Submits NDA for Single Tablet Combo to Treat PAH (Zacks)
May-30-23 10:56AM	Lexicon's (LXRX) Heart Failure Drug Inpefa Gets FDA Approval (Zacks)
May-29-23 09:40AM	Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? (Zacks)
May-26-23 08:23AM	PDS Biotech (PDSB) Up 32% on Interim Data From HPV Cancer Study (Zacks)
May-25-23 03:16PM	Immutep (IMMP) Up on Initial Data From Lung Cancer Study (Zacks)
May-24-23 11:37AM	Icosavax (ICVX) Up on Positive VLP Vaccine Candidate Data (Zacks)
08:14AM	INOVIA's (INO) Rare Disease Drug Gets EC's Orphan Tag, Stock Up (Zacks)
May-22-23 11:05AM	Krystal's (KRYS) Dermatology Drug Gets FDA Nod, Stock Up 10% (Zacks)
May-18-23 11:15AM	Ultragenyx's (RARE) GTX-102 Gets FDA Nod for Uniform Dosing (Zacks)
May-17-23 02:19PM	Intercept's (ICPT) Liver Drug Combo Gets FDA's Orphan Drug Tag (Zacks)
08:37AM	ADMA Biologics (NASDAQ:ADMA) rallies 18% this week, taking one-year gains to 102% (Simply Wall St.)
May-12-23 09:40AM	Is ADMA Biologics (ADMA) Stock Outpacing Its Medical Peers This Year? (Zacks) +6.57%
May-11-23 09:35AM	Q1 2023 ADMA Biologics Inc Earnings Call (Thomson Reuters StreetEvents) +10.92%
May-10-23 05:15PM	Adma Biologics (ADMA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	ADMA Biologics Announces First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
May-03-23 11:55AM	Horizon (HZNP) Q1 Earnings and Revenues Miss Estimates (Zacks) +5.45%
07:00AM	ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023 (GlobeNewswire)
May-02-23 07:00AM	ADMA Biologics Announces Amendment to Credit Agreement (GlobeNewswire)
Apr-18-23 11:43AM	Anixa (ANIX) Falls 25% Despite Positive Breast Cancer Study Data (Zacks)
11:20AM	Agenus (AGEN) Rises on Fast Track Tag for Cancer Combo Drug (Zacks)
Apr-17-23 03:25PM	Lacklustre Performance Is Driving ADMA Biologics, Inc.'s (NASDAQ:ADMA) Low P/S (Simply Wall St.) +5.03%
Apr-12-23 10:42AM	Adaptimmune (ADAP) Up 7%, Gets T-Cell Programs Rights From GSK (Zacks)
Mar-27-23 07:08AM	ADMA Biologics, Inc. (NASDAQ:ADMA) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-26-23 09:22AM	Institutional investors are ADMA Biologics, Inc.'s (NASDAQ:ADMA) biggest bettors and were rewarded after last week's US$53m market cap gain (Simply Wall St.)
Mar-24-23 09:37AM	Q4 2022 ADMA Biologics Inc Earnings Call (Thomson Reuters StreetEvents) +6.75%
Mar-23-23 05:45PM	Adma Biologics (ADMA) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	ADMA Biologics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update (GlobeNewswire)
Mar-16-23 07:00AM	ADMA Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on March 23, 2023 (GlobeNewswire)
Mar-03-23 09:48AM	ADMA Biologics, Inc.'s (NASDAQ:ADMA) Profit Outlook (Simply Wall St.)
Mar-01-23 09:36AM	Allogene (ALLO) Incurs Narrower-Than-Expected Loss in Q4 (Zacks)
Feb-28-23 09:10AM	BioMarin (BMRN) Q4 Earnings Miss, Sales Beat, Stock Down (Zacks)
Feb-19-23 02:05PM	7 A-Rated Penny Stocks Worth Betting On (InvestorPlace)
Feb-12-23 10:56AM	7 A-Rated Healthcare Stocks to Buy for the Future of Medicine (InvestorPlace)
Feb-08-23 07:00AM	ADMA BioCenters Receives FDA Approval for its Eighth Plasma Collection Center, Located in Hammond, LA (GlobeNewswire)
Feb-07-23 10:17AM	Sage and Biogen's NDA for Depression Drug Gets Priority Review (Zacks)
Jan-17-23 07:00AM	ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2022 Revenues and Provides 2023 Financial Guidance (GlobeNewswire)
Dec-28-22 11:58PM	12 Best Performing NASDAQ Stocks in 2022 (Insider Monkey)
10:15PM	12 Best Performing Biotech Stocks in 2022 (Insider Monkey)
Dec-13-22 07:00AM	ADMA Biologics Announces FDA Approval for Room Temperature Storage of ASCENIV & BIVIGAM® (GlobeNewswire)
Dec-11-22 08:41AM	Adam Grossman Is The Co-Founder of ADMA Biologics, Inc. (NASDAQ:ADMA) And They Just Picked Up 1.2% More Shares (Simply Wall St.)
Dec-09-22 04:05PM	ADMA Biologics Announces Closing of $69 Million Public Offering Including Full Exercise of Underwriters Option to Purchase Additional Shares (GlobeNewswire)
Dec-07-22 08:45AM	ADMA Biologics Announces Pricing of Public Offering for $60 Million of Common Stock (GlobeNewswire) +8.83%
Dec-06-22 04:05PM	ADMA Biologics Announces Proposed Public Offering of Common Stock (GlobeNewswire)
04:01PM	ADMA Biologics Announces Preliminary Fourth Quarter 2022 Revenue Estimate (GlobeNewswire)
Nov-30-22 02:47PM	Top Penny Stocks (Investopedia)
Nov-11-22 05:28AM	ADMA Biologics Third Quarter 2022 Earnings: Beats Expectations (Simply Wall St.)
Nov-09-22 05:35PM	Adma Biologics (ADMA) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -5.36%
04:05PM	ADMA Biologics Announces Third Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Nov-02-22 07:00AM	ADMA Biologics to Report Third Quarter 2022 Financial Results on November 9, 2022 (GlobeNewswire)
Oct-31-22 07:00AM	ADMA BioCenters Receives FDA Approval for its Seventh Plasma Collection Center, Located in Greensboro, NC (GlobeNewswire)
Oct-17-22 07:05AM	ADMA Biologics, Inc. (NASDAQ:ADMA) is largely controlled by institutional shareholders who own 53% of the company (Simply Wall St.)
Sep-23-22 02:25PM	7 A-Rated Stocks to Buy for Less Than $10 (InvestorPlace) -8.20%
Sep-15-22 03:00PM	7 Top-Rated Biotech Stocks to Buy for Q4 (InvestorPlace)
Aug-11-22 06:08PM	Why ADMA Biologics Stock Triumphed on Thursday (Motley Fool) +5.19%
Aug-10-22 05:25PM	Adma Biologics (ADMA) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	ADMA Biologics Announces Second Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
07:16AM	ADMA Biologics, Inc. (NASDAQ:ADMA) insiders placed bullish bets worth US$580k in the last 12 months (Simply Wall St.)
Aug-08-22 10:00AM	Analysts Estimate Vascular Biogenics (VBLT) to Report a Decline in Earnings: What to Look Out for (Zacks)
Aug-03-22 10:00AM	Adma Biologics (ADMA) May Report Negative Earnings: Know the Trend Ahead of Q2 Release (Zacks)
07:00AM	ADMA Biologics to Report Second Quarter 2022 Financial Results on August 10, 2022 (GlobeNewswire)
Jun-26-22 09:11AM	Shareholders in ADMA Biologics (NASDAQ:ADMA) have lost 50%, as stock drops 12% this past week (Simply Wall St.)
Jun-21-22 07:00AM	ADMA Biologics Announces Addition to the Russell 2000® Index (GlobeNewswire)
May-11-22 05:45PM	Adma Biologics (ADMA) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -11.18%
04:05PM	ADMA Biologics Announces First Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Grossman Jerrold B	Director	Aug 30	Buy	3.71	130,000	482,144	443,265	Aug 30 04:58 PM
KWON YOUNG	Director	Aug 24	Buy	3.90	25,000	97,500	277,401	Aug 24 07:53 PM
Fong Bryant	Director	Aug 22	Sale	3.87	1,433,304	5,544,737	0	Aug 23 08:30 PM
Grossman Adam S	President and CEO	Aug 18	Sale	4.15	250,000	1,038,350	2,273,085	Aug 18 09:46 PM
LENZ BRIAN	EVP, CFO	Aug 16	Sale	4.45	178,184	793,400	782,013	Aug 17 09:30 PM
Grossman Adam S	President and CEO	Aug 16	Sale	4.38	3	13	2,523,085	Aug 17 09:30 PM
Grossman Adam S	President and CEO	Aug 15	Option Exercise	3.11	2,100,459	6,536,448	4,623,544	Aug 17 09:30 PM
LENZ BRIAN	EVP, CFO	Aug 15	Option Exercise	3.11	809,262	2,514,363	1,591,275	Aug 17 09:30 PM
Grossman Adam S	President and CEO	Aug 15	Sale	4.54	510,469	2,318,959	4,113,075	Aug 17 09:30 PM
LENZ BRIAN	EVP, CFO	Aug 15	Sale	4.60	211,578	972,730	782,013	Aug 17 09:30 PM
Grossman Adam S	President and CEO	Dec 09	Buy	2.86	14,983	42,851	2,203,708	Dec 09 04:41 PM
Grossman Adam S	President and CEO	Dec 09	Buy	2.86	14,982	42,849	1,143,426	Dec 09 04:41 PM
LENZ BRIAN	EVP, CFO	Dec 09	Buy	2.86	6,993	20,000	1,034,825	Dec 09 04:41 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ADMA | ADMA Biologics, Inc.

Upgrade your FINVIZ experience